J&J on track to get 2.2m one-jab vaccines to Ireland
Senior executive Johan Van Hoof says disparate global production centres will ensure the rollout won’t be affected by any US export ban
Pharma giant Johnson & Johnson will partner with other companies and outsource some production of its Covid-19 vaccine through a global network of factories to deliver 200 million doses to Europe in 2021, a senior executive at the company has told the Business Post.
Johan Van Hoof is the global therapeutic area head for Janssen R&D, a subsidiary of Johnson and Johnson (J&J). The company has recently received clearance from the European Medicines Agency for...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Government faces fresh calls to lobby EU to back vaccine IP waiver
Amnesty writes to Stephen Donnelly urging him to use Ireland’s EU status to force an intellectual property rights waiver onto G20 agenda
Vaccine age restrictions create a ‘two-tier’ rollout, says immunologist
Professor Kingston Mills has warned that the new rules mean higher risk groups are getting less effective vaccines
New vaccine deals to deliver 20 million doses by end of 2023
HSE scrambles to reorganise ongoing rollout amid disruption to over-50s plan while IBM and Salesforce are hired to develop vaccine passport app to restart travel sector
Tony O’Brien: High-speed reopening gives no time to evaluate its impact
The government’s reopening plan comes with the knowledge that the vaccine programme here needs to be substantially completed if its gains are to mean anything